Curative Effectiveness of Erigeron Breviscapus Combined with Mexobalamin in the Treatment of Diabetic Peripheral Neuropathy
Li Han
Abstract
Li Han
Abstract
Objective:To discuss the curative effectiveness of erigeron breviscapus combined with mexobalamin in the treatment of diabetic peripheral neuropathy. Methods:106 patients with diabetes were randomly divided into two groups with 53 patients in each group. The patients in two groups were all treated with hypoglycemic drugs or insulin. The patients in the erigeron breviscapus and mexobalamin group were treated with erigeron breviscapus (50 mg) and mexobalamin (500 μg) combined, once a day, and those in the control group were treated with mexobalamin (500 μg) alone, daily once. The treatment courses were 4 weeks. Results:The effective rate in the erigeron breviscapus and mexobalamin group was 83% after 4 weeks and 84.9% after 6 weeks respectively, and the improvement degree of nerve conduction speed was significantly better than that in control group (P0.01). Conclusion:Erigeron breviscapus combined with mexobalamin to treat diabetic peripheral neuropathy is an effective therapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To discuss the curative effectiveness of erigeron breviscapus combined with mexobalamin in the treatment of diabetic peripheral neuropathy. Methods:106 patients with diabetes were randomly divided into two groups with 53 patients in each group. The patients in two groups were all treated with hypoglycemic drugs or insulin. The patients in the erigeron breviscapus and mexobalamin group were treated with erigeron breviscapus (50 mg) and mexobalamin (500 μg) combined, once a day, and those in the control group were treated with mexobalamin (500 μg) alone, daily once. The treatment courses were 4 weeks. Results:The effective rate in the erigeron breviscapus and mexobalamin group was 83% after 4 weeks and 84.9% after 6 weeks respectively, and the improvement degree of nerve conduction speed was significantly better than that in control group (P0.01). Conclusion:Erigeron breviscapus combined with mexobalamin to treat diabetic peripheral neuropathy is an effective therapy.
Key concepts: Medicine, Peripheral neuropathy, Peripheral, Diabetic neuropathy, Diabetes mellitus, Internal medicine, Endocrinology